Targeting Lymphoma By the Bi-Functional Hexameric Fusion Protein CTLA4-Fasl; Mode-of-Action, Pre-Clinical Efficacy and Toxicology Studies

Autor: Aronin, Alexandra *, Amsili, Shira *, Prigozhina, Tatyana *, Baru, Moshe *, Makdasi, Efi *, Tzdaka, Kobi *, Shkedy, Fanny *, Shani, Noam *, Dranitzki Elhalel, Michal *
Zdroj: In Blood 3 December 2015 126(23):1553-1553
Databáze: ScienceDirect